SAN DIEGO, Dec. 17, 2014 /PRNewswire-iReach/ -- eLux Medical, Inc., developer of NanoLipo, a novel nanomedicine approach to liposuction, is pleased to announce that Peter C. Farrell, PhD, DSc, AM, has joined its Business Advisory Board. Dr. Farrell is founder and chairman of the board of ResMed, director of NuVasive, Inc. and non-executive chair of QRxPharma. He is a Fellow or Honorary Fellow of several professional bodies, including the Australian Academy of Technological Sciences and Engineering. He has served as vice president of research and development at various subsidiaries of Baxter Healthcare as well as managing director of the Baxter Center for Medical Research. Dr. Farrell also serves on faculty Advisory Boards at UCSD: the Rady Business School, the Jacobs Engineering School and Health Sciences. He holds a B.E. in chemical engineering with honors from the University of Sydney, an S.M. in chemical engineering from the Massachusetts Institute of Technology. Dr. Farrell’s full biography can be found at http://investor.resmed.com.
Photo - http://photos.prnewswire.com/prnh/20141217/165025
“eLux Medical brings together the scientific, engineering and medical team needed for the application of gold nanotechnology to the practice of aesthetic medicinein this case to much improved techniques for liposuction procedures. I am delighted to join the eLux advisory team at this pivotal time and look forward to helping eLux build its leadership position in the application of gold nanotechnology to aesthetic medicine” said Dr. Farrell.
Dr. Farrell will advise eLux with the ongoing development of their corporation as well as its technology while the company prepares for the clinical trial phase of NanoLipo, a proprietary injectable solution of gold nanoparticles which is projected to transform the performance and results of liposuction, the number one cosmetic surgery worldwide.
About Dr. Farrell joining eLux Medical, Inc. Founder and CEO Prof. Adah Almutiari said,“we are proud to have Dr. Farrell as an advisor. Dr. Farrell’s background in business and medical technology is of great value to eLux especially as we move into clinical trials”
About eLux Medical, Inc.
San Diego based eLux Medical is a development stage company, which has spun out of the University of California San Diego (UCSD) Center of Excellence in Nanomedicine, of which Professor Adah Almutairi is the Director. eLux Medical has an exclusive worldwide license on the intellectual property related to NanoLipo from UCSD.
About Forward-Looking Statements
The Company cautions you that the statements included in the press release that are not a description of historical facts are forward-looking statements. These include statements regarding the potential clinical benefits of NanoLipo and the commercial prospects of eLux Medical, Inc. NanoLipo is an investigational device and is not approved for sale in the USA or any other country.
CONTACT
Adah Almutairi, Founder
858-232-7848
adah.almutairi@eluxmedical.com
MEDIA
Chris Smith
858-220-6939
Media Contact: chris smith, eLux Medical Inc,, 8582206939, chrissmith@eluxmedical.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE eLux Medical Inc.
Help employers find you! Check out all the jobs and post your resume.
